| Literature DB >> 34868452 |
Nannan Jiang1,2,3, Wei Xu1,2,3, Li Xiang4,3.
Abstract
BACKGROUND: Little is known about anaphylaxis in Chinese children. This study aimed to determine the age-specific patterns of anaphylaxis in Chinese children.Entities:
Keywords: Anaphylaxis; Food allergy; Infancy; Vaccine
Year: 2021 PMID: 34868452 PMCID: PMC8605427 DOI: 10.1016/j.waojou.2021.100605
Source DB: PubMed Journal: World Allergy Organ J ISSN: 1939-4551 Impact factor: 4.084
Characteristics of the 177 children with anaphylaxis.
| Characteristics | patients, no (%) |
|---|---|
| 0-2 years | 102 (57.6) |
| 3-6 years | 34 (19.2) |
| 7-12 years | 31 (17.5) |
| 13-17 years | 10 (5.6) |
| Male | 119 (67.2) |
| AR/AC | 44 (24.8) |
| AS/recurrent wheezing | 61 (34.4) |
| AD | 44 (24.8) |
| 71 (40.1) | |
| 1 | 106 (59.8) |
| 2 | 49 (27.7) |
| 3 | 16 (9.0) |
| 4 | 5 (2.8) |
| 5 | 1 (0.5) |
Abbreviations: AR/AC, allergic rhinitis/conjunctivitis; AS, asthma; AD, atopic dermatitis
Triggers of the 279 anaphylactic reactions.
| Age, year, median (range) | Total, n = 279, n (%) | Age groups | |||||
|---|---|---|---|---|---|---|---|
| 0–2years (n = 140) | 3–6 years (n = 64) | 7–12years (n = 57) | 13–17years (n = 18) | P value | |||
| Suspect triggers | |||||||
| foods | 4.2 (2 ms-15 years) | 247 (88.5) | 134 (95.7) | 55 (85.9) | 47 (82.5) | 11 (61.1) | <0.001 |
| milk | 3.3 (2 ms-8 years) | 53 (19.0) | 46 (32.9) | 3 (4.7) | 4 (7) | 0 (0) | <0.001 |
| egg | 1.4 (4 ms-13 years) | 31 (11.1) | 30 (21.4) | 0 (0) | 0 (0) | 1 (5.6) | <0.001 |
| wheat | 1.0 (5 ms-4 years) | 30 (10.8) | 29 (20.7) | 1 (1.5) | 0 (0) | 0 (0) | <0.001 |
| buckwheat | 5.6 (2–11 years) | 12 (4.3) | 2 (1.4) | 7 (10.9) | 3 (5.3) | 0 (0) | 0.014 |
| corn | 10 years | 1 (0.4) | 0 (0) | 0 (0) | 1 (1.8) | 0 (0) | 0.269 |
| peanut | 6.9 (7 ms-10 years) | 4 (1.4) | 1 (0.7) | 0 (0) | 3 (5.3) | 0 (0) | 0.02 |
| nuts | 5.0 (23 ms-13 years) | 14 (5.0) | 4 (2.9) | 6 (9.4) | 3 (5.3) | 1 (5.6) | 0.141 |
| soybean | 7.5 (2–11 years) | 6 (2.2) | 1 (0.7) | 2 (3.1) | 3 (5.3) | 0 (0) | 0.156 |
| fruit and vegetable | 6.5 (2–15 years) | 50 (17.9) | 8 (5.7) | 23 (35.9) | 18 (31.6) | 1 (5.6) | <0.001 |
| seafoods | 4.5 (8 ms-13 years) | 13 (4.7) | 7 (5) | 3 (4.7) | 2 (3.5) | 1 (5.6) | 0.973 |
| spices | 5.7 (3–8 years) | 6 (2.2) | 1 (0.7) | 2 (3.1) | 3 (5.3) | 0 (0) | 0.156 |
| mix foods | 5.2 (11 ms-13 years) | 13 (4.7) | 5 (3.6) | 5 (7.8) | 2 (3.5) | 1 (5.6) | 0.595 |
| foods unclear | 10.4 (4–15years) | 14 (5.0) | 0 (0) | 3 (4.7) | 5 (8.8) | 6 (33.3) | <0.001 |
| foods + exercise/exercise | 12.3 (9–14 years) | 13 (4.7) | 0 (0) | 1 (1.6) | 7 (12.3) | 5 (27.8) | <0.001 |
| drug | 3.5 (3 ms-6 years) | 12 (4.3) | 6 (4.3) | 6 (9.3) | 0 (0) | 0 (0) | 0.062 |
| idiopathic | 8.6 (4–14 years) | 7 (2.5) | 0 (0) | 2 (3.1) | 3 (5.3) | 2 (11.1) | |
Fruits and vegetables include: peach (n = 9), pitaya (n = 6), mango (n = 6), lychee (n = 5), pear (n = 3), Physalis peruviana L (n = 2), longan (n = 2), apple (n = 2), melon (n = 1), rambutan (n = 2), orange (n = 1), blueberry (n = 1), cauliflower (n = 1), kiwifruit (n = 1), grape (n = 1), sea buckthorn (n = 1), and watermelon (n = 1), cherry (n = 1).
Nuts include: walnut (n = 8), cashew nut (n = 3), pistachio nut (n = 2), almond (1), hazelnut (n = 2), not specified (n = 1).
Mix foods represented that the offending foods may contain multiple potential allergens several food allergens, such as cake, cookies,pizza; food unclear represented the food triggers were not determined during chart review, such as the reactions occur just after a meal that may ingest several foods
Fig. 1The anaphylactic triggers for the 279 anaphylactic events. A. The anaphylactic triggers for the 279 anaphylactic events (food 88.5%, food + exercise/exercise 4.7%, drug 4.3%, idiopathic 2.5%); B. When analyzing the differences between triggers with regards to age groups, food-induced anaphylaxis were more common in the age group 0–2 years, while food + exercise/exercise-induced and idiopathic anaphylaxis were significantly higher in the age group 13–17 years; C. When comparing the differences between food causes with regards to age groups, milk, egg, and wheat were significantly more common in infants; Fruits/vegetables were significantly more frequent in children aged 3–6 years and children aged 7–12 years.
Characteristics of medication-induced anaphylaxis in five severe cow's milk allergy patients.
| case | age(y)/sex | history of allergy | symptoms of food allergy | drug triggers | Route of intramuscular | clinical reaction to drug | T-IgE(KU/L) | sIgE of food allergens (KUA/L) | sIgE of aeroallergens (KUA/L) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1/F | CMA | CMA:anaphylaxis | DTaP | intramuscular | Cyanosis, palpebral edema | 237 | cow's milk>100, egg-0.71 | T-IgE 237, cat dander-1.30, dog dander-11.5 |
| 2 | 2/M | CMA, wheat allergy, asthma | CMA:anaphylxsi; WA (wheat allergy):anaphylaxis | DTaP 、Group A + C Meningococcal Polysaccharide Vaccine | intramuscular | DTaP: urticaria、wheezing, shortness of breath; Group A + C Meningococcal Polysaccharide Vaccine:cyanosis,breathing difficulty, urticaria | 1756 | cow's milk>100,egg-14.3,wheat-36.9, peanut-2.89,soybean-9.68 | T-IgE 1756, Der p-0.56, Der f-0.48KUA/L,Alternaria-0.36,cockroach-1.93, cat dander -4.84, dog dander-15.9, Artemisia vulgaris-1.49, Ambrosia elatior-2.59 |
| 3 | 2/F | CMA,AR | CMA:urticaria; | lacidophilin tablets | oral | breathing difficulty,urticaria | 332 | cow's milk-46.7, egg-12.7,wheat-0.79 | T-IgE 332, cat dander-1.73, dog dander-6.40 |
| 4 | 3/M | CMA, egg allergy, soybean allergy, AD AS | CMA:anaphylaxis; soybean allergy: anaphylaxis; egg allergy:omitting | probiotics、propofol | Oral (probiotics) | probiotics:urticaria、wheezing; propofol:urticaria,wheezing | 3223 | egg-87.3,cow's milk->100,wheat-50.4,peanut-31.8,soybean-23.3,crab-1.14,shrimp-1.14; | T-IgE 3223, Der P-2.24, Der f-0.68, Aspergillus fumigatus-6.01, Alternaria-8, cat dander-17.7, dog dander-81.8, Ambrosia elatior-2.72, Artemisia vulgaris-11.1; |
| 5 | 5/M | CMA, egg allergy | CMA:urticaria; egg allergy: urticaria | Sabin vaccine | intramuscular | loss of consciousness | unrecorded | unrecorded |
CMA: cow's milk allergy; DTaP: diphtheria, tetanus, and pertussis vaccine
Symptoms of the 279 anaphylaxis events
| Total n = 279,n (%) | 0–2years (n = 140) infants | 3–6 years (n = 64) preschool children | 7–12years (n = 57) | 13–17years (n = 18) | P value | |
|---|---|---|---|---|---|---|
| Symptoms, n (%) | ||||||
| 240 (86.0) | 124 (88.6) | 51 (79.7) | 48 (84.2) | 17 (94.4) | 0.273 | |
| Hives | 168 (60.2) | 96 (77.4) | 32 (50.0) | 33 (57.9) | 7 (38.9) | |
| Itching | 25 (9.0) | 8 (6.5) | 6 (0.9) | 7 (12.3) | 4 (22.2) | 0.082 |
| Redness/Rash | 6 (2.1) | 4 (3.2) | 1 (1.6) | 0 (0) | 1 (5.6) | 0.327 |
| Angioedema | 77 (27.6) | 42 (33.9) | 14 (21.9) | 16 (28.1) | 5 (27.8) | 0.654 |
| 33 (11.8) | 16 (11.4) | 12 (18.8) | 3 (5.3) | 2 (11.1) | 0.143 | |
| Throat closing or swelling | 22 (7.9) | 10 (7.1) | 8 (12.5) | 2 (3.5) | 2 (11.1) | 0.249 |
| Difficulty swallowing | 1 (0.4) | 1 (0.7) | 0 (0) | 0 (0) | 0 (0) | 1 |
| Throat tingling or itching | 7 (2.5) | 3 (2.1) | 3 (4.7) | 1 (1.8) | 0 (0) | 0.484 |
| Hoarseness | 5 (1.8) | 4 (2.9) | 1 (1.6) | 0 (0) | 0 (0) | 0.724 |
| 192 (68.8) | 92 (65.7) | 42 (65.6) | 45 (78.9) | 13 (72.2) | 0.295 | |
| wheezing | 69 (24.7) | 30 (21.4) | 16 (25) | 1 (5.6) | ||
| shortness of breath | 44 (15.8) | 13 (9.3) | 12 (18.6) | |||
| Breathing difficulty | 103 (36.9) | 54 (38.5) | 18 (28.1) | 20 (35.1) | 11 (61.1) | 0.076 |
| cough | 51 (18.3) | 28 (20.0) | 12 (18.8) | 11 (19.3) | 0 (0) | 0.179 |
| 66 (23.7) | 34 (24.3) | 12 (18.8) | 14 (24.6) | 6 (33.3) | 0.58 | |
| nausea | 1 (0.4) | 0 (0) | 0 (0) | 1 (1.8) | 0 (0) | 0.269 |
| pain | 34 (12.2) | 3 (2.1) | 10 (15.6) | 8 (14.0) | <0.001 | |
| vomiting | 39 (14.0) | 1 (1.6) | 5 (8.8) | 4 (22.2) | <0.001 | |
| diarrhea | 9 (3.2) | 4 (2.9) | 2 (3.1) | 3 (5.3) | 0 (0) | 0.783 |
| 2 (0.7) | 2 (1.4) | 0 (0) | 0 (0) | 0 (0) | 0.31 | |
| hypotension | 2 (0.7) | 2 (1.4) | 0 (0) | 0 (0) | 0 (0) | 0.31 |
| 29 (10.4) | 17 (12.1) | 4 (6.3) | 6 (10.5) | 2 (11.1) | 0.851 | |
| persistent crying, restlessness | 9 (3.2) | 9 (6.4) | 0 (0) | 0 (0) | 0 (0) | |
| loss of consciousness/Confusion | 20 (7.2) | 8 (5.7) | 4 (6.3) | 6 (10.5) | 2 (11.1) | 0.214 |
| incontinence | 1 (0.4) | 1 (0.7) | 0 (0) | 0 (0) | 0 (0) | 1 |
| 31 (11.1) | 16 (11.4) | 8 (12.5) | 5 (8.7) | 3 (16.6) | 0.845 |
Treatments administered in 225 anaphylaxis events
| Treatment | Total n = 225,n (%) | mild/moderate,n = 196 | severe reactions n = 29 | P value |
|---|---|---|---|---|
| 85 (37.8) | 80 (40.8) | 5 (17.2) | ||
| Self-relief | 31 (13.8) | 28 (14.3) | 3 (10.3) | 0.377 |
| Oral antihistamines | 50 (22.2) | 48 (24.5) | 2 (6.9) | |
| Nebulized β-agonist | 6 (2.7) | 6 (3.1) | 0 | 0.419 |
| Oral Montelukast | 2 (0.9) | 2 (1.0) | 0 | 0.751 |
| 131 (58.2) | 110 (56.1) | 21 (72.4) | 0.052 | |
| Epinephrine | 21 (9.3) | 14 (7.1) | 7 (24.1) | |
| Systemic corticosteroid | 69 (30.7) | 58 (29.6) | 11 (37.9) | 0.164 |
| Antihistamines | 39 (17.3) | 32 (16.3) | 6 (20.7) | 0.243 |
| Nebulized β-agonist | 16 (7.1) | 15 (7.7) | 1 (3.4) | 0.617 |
| Oxygen Supplement | 3 (1.3) | 2 (1.0) | 1 (3.4) | 0.35 |
| unclear | 13 (5.8) | 10 (5.1) | 3 (10.3) | 0.242 |
| 5 (2.2) | 3 (1.5) | 2 (6.9) | 0.133 | |
| 4 (1.8) | 3 (1.5) | 1 (3.4) | 0.438 |